×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [35]
南华大学 [7]
上海药物研究所 [7]
上海中医药大学 [4]
中南大学 [2]
西安交通大学 [1]
更多...
内容类型
期刊论文 [59]
会议论文 [4]
发表日期
2020 [2]
2019 [10]
2018 [6]
2017 [8]
2016 [6]
2015 [10]
更多...
学科主题
Fisheries;... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共63条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 3, 页码: 327-335
作者:
Li, Hui-hui
;
Li, Jun
;
Zhang, Xian-jing
;
Li, Jiao-meng
;
Xi, Cong
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/07/01
23,24-dihydrocucurbitacin B
lipid-lowering agent
LDLR
PCSK9
HNF1 alpha
SREBP2
2324dihydrocucurbitacinbpromoteslipidclearancebydualtranscriptionalregulationofldlrandpcsk9
期刊论文
actapharmacologicasinica, 2020, 卷号: 41, 期号: 3, 页码: 327
作者:
Li Huihui
;
Li Jun
;
Zhang Xianjing
;
Li Jiaomeng
;
Xi Cong
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2020/07/01
23
24-dihydrocucurbitacin B
lipid-lowering agent
LDLR
PCSK9
HNF1α
SREBP2
Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia
期刊论文
ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 6, 页码: 1216-1230
作者:
Wu, Chenglin
;
Xi, Cong
;
Tong, Junhua
;
Zhao, Jing
;
Jiang, Hualiang
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2020/07/01
PCSK9
Tetrahydroprotoberberine derivatives
Low-density lipoprotein cholesterol
Lipid-lowering
PCSK9 expression
Low-density lipoprotein receptor
Total cholesterol
Hyperlipidemia hamster
Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE-/- Mice.
期刊论文
Chinese journal of integrative medicine, 2019
作者:
Jia Qing-Ling
;
Dou Fang-Fang
;
Xing San-Li
;
Chen Chuan
;
Shen Ding-Zhu
收藏
  |  
浏览/下载:67/0
  |  
提交时间:2019/12/05
ATP binding cassette transporter A1
atherosclerosis
liver X receptor
proprotein convertase subtilisin/kexin type 9
quercetin
Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice
期刊论文
JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2019, 卷号: 39, 期号: 4
作者:
Jia Qingling
;
Li Shanshan
;
Cao Hui
;
Shen Dingzhu
;
Chen Chuan
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/05
Atherosclerosis
ATP-binding cassette transporters
Proprotein convertases
Toll-like receptor 4
NF-kappa B
Shoushen granule
Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice
期刊论文
Journal of Traditional Chinese Medicine, 2019, 卷号: 39, 期号: 4
作者:
Li Shanshan
;
Cao Hui
;
Shen Dingzhu
;
Chen Chuan
;
Xing Sanli
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Atherosclerosis
ATP-binding cassette transporters
Proprotein convertases
Toll-like receptor 4
NF-kappa B
Shoushen granule
Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPAR gamma, LXR alpha and ABCA1
期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 卷号: 44, 期号: 3
作者:
Jia, Qingling
;
Xing, Sanli
;
Dou, Fangfang
;
Cao, Hui
;
Shen, Dingzhu
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/12/05
quercetin
atherosclerosis
proprotein convertase subtilisin
kexin type 9
cluster of differentiation 36
peroxisome proliferator-activated receptor gamma
liver X receptor alpha
ATP binding cassette transporter A1
PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
期刊论文
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 卷号: 19, 期号: 2, 页码: 165-176
作者:
Wang, Yan
;
Liu, Zhao-Peng
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/12/11
Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9)
low-density lipoprotein cholesterol (LDL-C)
low-density lipoprotein
receptor (LDLR)
cardiovascular disease (CVD)
hypercholesterolemia
alirocmab
evolocumab
Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis
期刊论文
2019, 卷号: 105, 期号: 15, 页码: 1149-1159
作者:
Du, Heyue
;
Li, Xiaodan
;
Su, Na
;
Li, Ling
;
Hao, Xiaoting
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
cardiovascular disease
low-density lipoprotein cholesterol
lipid-lowering drugs
proprotein convertase subtilisin
kexin type 9 inhibitors
systematic review
Hydrogen sulfide inhibits PCSK9 expression through the PI3K/AktSREBP2 signaling pathway to influence lipid metabolism in HepG2 cells.
期刊论文
International journal of molecular medicine, 2019, 卷号: 43, 期号: 5, 页码: 2055-2063
作者:
Xiao, Jun
;
Bai, Xue-Qin
;
Liao, Ling
;
Zhou, Min
;
Peng, Juan
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/27
HepG2 cells
Hydrogen sulfide
Lipid metabolism
Low-density lipoprotein receptor
Phosphoinositide 3-kinase/protein kinase B
Proprotein convertase subtilisin/kexin type 9
Sterol regulatory element-binding protein 2
©版权所有 ©2017 CSpace - Powered by
CSpace